Forte Biosciences (FBRX) EPS (Basic) (2016 - 2020)
Historic EPS (Basic) for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$0.0.
- Forte Biosciences' EPS (Basic) rose 9939.99% to -$0.0 in Q1 2020 from the same period last year, while for Sep 2020 it was -$1.78, marking a year-over-year decrease of 508030.02%. This contributed to the annual value of -$30.13 for FY2019, which is 113447.32% down from last year.
- Forte Biosciences' EPS (Basic) amounted to -$0.0 in Q1 2020, which was up 9939.99% from -$5.02 recorded in Q4 2019.
- Forte Biosciences' 5-year EPS (Basic) high stood at -$0.0 for Q1 2020, and its period low was -$5.02 during Q4 2019.
- Its 5-year average for EPS (Basic) is -$1.73, with a median of -$0.74 in 2017.
- As far as peak fluctuations go, Forte Biosciences' EPS (Basic) crashed by 41366.72% in 2019, and later surged by 9939.99% in 2020.
- Forte Biosciences' EPS (Basic) (Quarter) stood at -$3.85 in 2016, then skyrocketed by 80.71% to -$0.74 in 2017, then tumbled by 31.73% to -$0.98 in 2018, then crashed by 413.67% to -$5.02 in 2019, then skyrocketed by 99.91% to -$0.0 in 2020.
- Its last three reported values are -$0.0 in Q1 2020, -$5.02 for Q4 2019, and -$0.01 during Q3 2019.